{
  "source": "Comprehensive Epilepsy Medication Database",
  "description": "Extended database of epilepsy medications with pregnancy safety information",
  "extracted_at": "2025-10-05 17:45:00",
  "medications": [
    {
      "medication": "Lamotrigine",
      "brand_names": ["Lamictal"],
      "pregnancy_category": "Category C",
      "safety_profile": "Generally considered safer during pregnancy",
      "key_points": [
        "Lower risk of major congenital malformations compared to valproate",
        "May require dose adjustments during pregnancy",
        "Therapeutic drug monitoring recommended",
        "Considered safe for breastfeeding"
      ],
      "monitoring": [
        "Regular blood level monitoring",
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks"
      ]
    },
    {
      "medication": "Levetiracetam",
      "brand_names": ["Keppra"],
      "pregnancy_category": "Category C",
      "safety_profile": "Generally considered safer during pregnancy",
      "key_points": [
        "Lower risk of major congenital malformations",
        "Good seizure control during pregnancy",
        "May require dose adjustments",
        "Considered safe for breastfeeding"
      ],
      "monitoring": [
        "Regular blood level monitoring",
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks"
      ]
    },
    {
      "medication": "Valproic Acid",
      "brand_names": ["Depakote", "Depakene"],
      "pregnancy_category": "Category D",
      "safety_profile": "Higher risk during pregnancy",
      "key_points": [
        "Highest risk of major congenital malformations (10-11%)",
        "Increased risk of neurodevelopmental problems",
        "Should be avoided if possible during pregnancy",
        "If necessary, use lowest effective dose"
      ],
      "monitoring": [
        "High-dose folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Consider alternative medications if possible",
        "Close monitoring for birth defects"
      ]
    },
    {
      "medication": "Carbamazepine",
      "brand_names": ["Tegretol"],
      "pregnancy_category": "Category D",
      "safety_profile": "Moderate risk during pregnancy",
      "key_points": [
        "Risk of neural tube defects",
        "May cause vitamin K deficiency in newborn",
        "Requires folic acid supplementation",
        "Consider vitamin K supplementation in last month"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Vitamin K supplementation in last month",
        "Monitor for neural tube defects"
      ]
    },
    {
      "medication": "Phenytoin",
      "brand_names": ["Dilantin"],
      "pregnancy_category": "Category D",
      "safety_profile": "Moderate risk during pregnancy",
      "key_points": [
        "Risk of fetal hydantoin syndrome",
        "May cause vitamin K deficiency",
        "Requires careful monitoring",
        "Consider alternative medications"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Vitamin K supplementation in last month",
        "Monitor for fetal hydantoin syndrome"
      ]
    },
    {
      "medication": "Topiramate",
      "brand_names": ["Topamax"],
      "pregnancy_category": "Category D",
      "safety_profile": "Moderate risk during pregnancy",
      "key_points": [
        "Risk of cleft lip/palate",
        "May cause vitamin K deficiency",
        "Requires folic acid supplementation",
        "Consider alternative medications if possible"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Vitamin K supplementation in last month",
        "Monitor for cleft lip/palate"
      ]
    },
    {
      "medication": "Oxcarbazepine",
      "brand_names": ["Trileptal"],
      "pregnancy_category": "Category C",
      "safety_profile": "Moderate risk during pregnancy",
      "key_points": [
        "Lower risk than carbamazepine",
        "May cause vitamin K deficiency",
        "Requires folic acid supplementation",
        "Consider vitamin K supplementation"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Vitamin K supplementation in last month",
        "Monitor for birth defects"
      ]
    },
    {
      "medication": "Gabapentin",
      "brand_names": ["Neurontin"],
      "pregnancy_category": "Category C",
      "safety_profile": "Limited data during pregnancy",
      "key_points": [
        "Limited human data available",
        "Generally considered safer than older AEDs",
        "May require dose adjustments",
        "Consider alternative medications if possible"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Monitor for any adverse effects",
        "Consider alternative medications"
      ]
    },
    {
      "medication": "Pregabalin",
      "brand_names": ["Lyrica"],
      "pregnancy_category": "Category C",
      "safety_profile": "Limited data during pregnancy",
      "key_points": [
        "Limited human data available",
        "May cause birth defects in animal studies",
        "Requires careful monitoring",
        "Consider alternative medications"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Monitor for birth defects",
        "Consider alternative medications"
      ]
    },
    {
      "medication": "Clonazepam",
      "brand_names": ["Klonopin"],
      "pregnancy_category": "Category D",
      "safety_profile": "Higher risk during pregnancy",
      "key_points": [
        "Risk of withdrawal symptoms in newborn",
        "May cause respiratory depression",
        "Requires careful monitoring",
        "Consider alternative medications"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Monitor for withdrawal symptoms",
        "Consider alternative medications"
      ]
    },
    {
      "medication": "Lorazepam",
      "brand_names": ["Ativan"],
      "pregnancy_category": "Category D",
      "safety_profile": "Higher risk during pregnancy",
      "key_points": [
        "Risk of withdrawal symptoms in newborn",
        "May cause respiratory depression",
        "Use only if absolutely necessary",
        "Consider alternative medications"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Monitor for withdrawal symptoms",
        "Consider alternative medications"
      ]
    },
    {
      "medication": "Phenobarbital",
      "brand_names": ["Luminal"],
      "pregnancy_category": "Category D",
      "safety_profile": "Higher risk during pregnancy",
      "key_points": [
        "Risk of fetal hydantoin syndrome",
        "May cause vitamin K deficiency",
        "Requires careful monitoring",
        "Consider alternative medications"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Vitamin K supplementation in last month",
        "Monitor for fetal hydantoin syndrome"
      ]
    },
    {
      "medication": "Primidone",
      "brand_names": ["Mysoline"],
      "pregnancy_category": "Category D",
      "safety_profile": "Higher risk during pregnancy",
      "key_points": [
        "Risk of fetal hydantoin syndrome",
        "May cause vitamin K deficiency",
        "Requires careful monitoring",
        "Consider alternative medications"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Vitamin K supplementation in last month",
        "Monitor for fetal hydantoin syndrome"
      ]
    },
    {
      "medication": "Ethosuximide",
      "brand_names": ["Zarontin"],
      "pregnancy_category": "Category C",
      "safety_profile": "Limited data during pregnancy",
      "key_points": [
        "Limited human data available",
        "Generally considered safer than older AEDs",
        "May require dose adjustments",
        "Consider alternative medications if possible"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Monitor for any adverse effects",
        "Consider alternative medications"
      ]
    },
    {
      "medication": "Vigabatrin",
      "brand_names": ["Sabril"],
      "pregnancy_category": "Category C",
      "safety_profile": "Limited data during pregnancy",
      "key_points": [
        "Limited human data available",
        "May cause vision problems",
        "Requires careful monitoring",
        "Consider alternative medications"
      ],
      "monitoring": [
        "Folic acid supplementation (5mg daily)",
        "Detailed anomaly scan at 18-20 weeks",
        "Monitor for vision problems",
        "Consider alternative medications"
      ]
    }
  ],
  "general_guidelines": [
    "Pre-pregnancy counseling is essential",
    "Folic acid supplementation (5mg daily) before conception",
    "Regular monitoring of medication levels",
    "Multidisciplinary team approach",
    "Consider medication changes before pregnancy if possible"
  ]
}
